Alx Oncology Holdings (ALXO) Free Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 24.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.37% |
| Dec 31, 2025 | 40.73% |
| Sep 30, 2025 | 32.81% |
| Jun 30, 2025 | 12.02% |
| Mar 31, 2025 | 35.06% |
| Dec 31, 2024 | 19.38% |
| Sep 30, 2024 | 14.51% |
| Jun 30, 2024 | 20.31% |
| Mar 31, 2024 | -33.56% |
| Dec 31, 2023 | -89.13% |
| Sep 30, 2023 | 3.92% |
| Jun 30, 2023 | -93.86% |
| Mar 31, 2023 | -34.06% |
| Dec 31, 2022 | -18.64% |
| Sep 30, 2022 | -23.05% |
| Jun 30, 2022 | 16.33% |
| Mar 31, 2022 | -313.52% |
| Dec 31, 2021 | -30.26% |
| Sep 30, 2021 | -231.63% |
| Jun 30, 2021 | -154.40% |
| Mar 31, 2021 | 42.69% |
| Dec 31, 2020 | -384.57% |
| Sep 30, 2020 | -139.01% |